Velan Capital, L.P. is 10% Owner at PROGENICS PHARMACEUTICALS INC (PGNX). They have made 1 open-market trade across 1 company since 2019, most recently 2019-09-04.
CIK 0001785731
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4.6M since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PGNX | 7,696,096 | $31.6M |
Shares reported on the most recent Form 4, priced at the 2019-09-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PGNX | BUY | 2019-09-03 | 2019-09-05 | $4.45 | $4.6M | +16.0% | +10.5% | +5.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.